ClinicalTrials.gov
ClinicalTrials.gov Menu

Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00639301
Recruitment Status : Active, not recruiting
First Posted : March 20, 2008
Last Update Posted : April 18, 2018
Sponsor:
Collaborators:
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

Brief Summary:
The purpose of this study is to find out about the quality of life and health in a group of adults who had retinoblastoma when they were children. By quality of life, we mean how you are feeling about being satisfied with things in your life, including your physical health, your emotional health, and your ability to carry out daily activities. We hope that this information will help us provide better care to future children with retinoblastoma and better follow-up care for survivors of retinoblastoma.

Condition or disease Intervention/treatment
Retinoblastoma Behavioral: Questionnaires

Study Type : Observational
Actual Enrollment : 473 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
Actual Study Start Date : March 2008
Estimated Primary Completion Date : March 2019
Estimated Study Completion Date : March 2019

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
1
adult survivors of retinoblastoma
Behavioral: Questionnaires
The survey will be administered by mail or telephone interview, based upon the participant preference. The survey has been adapted from the 2008 questionnaire being administered through the CCSS (11); it has been supplemented with questions addressing areas of interest specific to the retinoblastoma survivor population (eg, validated instruments that assess visual impairment).




Primary Outcome Measures :
  1. To describe the long-term health status of adult survivors of childhood retinoblastoma, General medical outcomes, vision status, Rates of second cancer [ Time Frame: conclusion of study ]

Secondary Outcome Measures :
  1. To describe the quality of life and psychosocial functioning of adult survivors of childhood retinoblastoma Fear of disease recurrence/development of other cancers, Health behaviors, Body image, etc. [ Time Frame: conclusion of study ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult survivors of retinoblastoma will be identified via the NCI and New York (MSKCC)databases and offered participation in the study.
Criteria

Inclusion Criteria:

  • Patient diagnosed with retinoblastoma at any age
  • At least 18 years at the time of study enrollment
  • Able to provide informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00639301


Locations
United States, New York
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Investigators
Principal Investigator: Ira Dunkel, MD Memorial Sloan Kettering Cancer Center

Additional Information:
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00639301     History of Changes
Other Study ID Numbers: 08-019
First Posted: March 20, 2008    Key Record Dates
Last Update Posted: April 18, 2018
Last Verified: April 2018

Keywords provided by Memorial Sloan Kettering Cancer Center:
Survivor
Quality of Life
Eye

Additional relevant MeSH terms:
Retinoblastoma
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Retinal Neoplasms
Eye Neoplasms
Neoplasms by Site
Eye Diseases
Retinal Diseases